Long Ideas - Questcor Pharmaceuticals (NASDAQ:QCOR) announced this morning that it can now start making money on the prescriptions of H.P. Acthar Gel that the company sells to … Continue Reading
Read NowLong Ideas - Since reporting 2Q earnings on August 2nd, Threshold Pharmaceuticals (NASDAQ:THLD) gained 25% and is on track to end the month around $8.70, a $.50 premium … Continue Reading
Read NowLong Ideas - In a press release after the markets closed on Thursday, Achillion Pharmaceuticals (NASDAQ:ACHN) announced that the company will be selling $41.8M in common stock to … Continue Reading
Read NowLong Ideas - Forest Laboratories (NYSE:FRX) and partner Ironwood Pharmaceuticals (NASDAQ:IRWD) announced FDA approval of Linzess (generically known as linaclotide) for the treatment of irritable bowel syndrome with … Continue Reading
Read NowLong Ideas - Sucampo Pharmaceuticals (NASDAQ:SCMP) announced that the the only holder of its Class B shares had converted them all into Class A common stock on a … Continue Reading
Read NowLong Ideas - On Wednesday, the FDA removed Exelixis’ (NASDAQ:EXEL) lead candidate cabozantinib from the agenda of the Oncology Drugs Advisory Committee (ODAC) meeting in early November, but … Continue Reading
Read NowLong Ideas - The CEO of Spectrum Pharmaceuticals (NASDAQ:SPPI) will present today in Southern California at an investor conference (12:00pm EST, webcast available at www.sppirx.com). In addition to … Continue Reading
Read Now